Karius

As of Monday, March 17, 2025 the Karius Test has been rebranded to Karius Spectrum. The same test, still detecting over 1000 pathogens from a single blood sample with just 1 day of processing time... Just with a new look! #InfectiousDisease #MetagenomicSequencing #KariusSpectrum

We're thrilled to announce that the Karius Test is now Karius Spectrum! While the product remains the same, this rebrand helps us pave the way for future enhancements. #InfectiousDisease #MetagenomicSequencing #KariusSpectrum

We have some exciting news! As part of our ongoing commitment to innovation and growth, we’ve decided to give the Karius Test a fresh new look. ?? As of today, March 17, 2025, the Karius Test will be rebranded to Karius Spectrum. While the product itself remains the same, this rebrand will help us pave the way for future enhancements. #InfectiousDisease #MetagenomicSequencing #KariusSpectrum #Innovation

The test you know and love is getting a facelift... Details to come next week. Stay tuned! #InfectiousDisease #MetagenomicSequencing #Teaser #ExcitingNews #Innovation

A fresh new perspective on the Karius Test is coming your way. Check back tomorrow for a final teaser before the big reveal... #InfectiousDisease #MetagenomicSequencing #Teaser #ExcitingNews #Innovation

Can you feel it? Innovation is in the air... #InfectiousDisease #MetagenomicSequencing #Teaser #ExcitingNews #Innovation

We've been working on something exciting and can't wait to share it with you! Keep checking back this week to learn more... #InfectiousDisease #MetagenomicSequencing #Teaser #ExcitingNews #Innovation

At Karius, our success is driven by the dedication, talent, and hard work of our incredible team. We do what we do because we believe in the power of innovation and compassion to transform lives. Today, we celebrate and thank every employee for their commitment, innovation, and passion. We understand the vulnerability of immunocompromised patients and are committed to delivering solutions that ensure their safety and well-being. Together, we strive to make a difference—one patient at a time. Thank you to our amazing team for your unwavering commitment and hard work. You are the heart of Karius, and your efforts create a lasting impact in the lives of many! #EmployeeAppreciationDay #TeamKarius #Gratitude #OurPeopleOurStrength #ThankYou #KariusTeam #EmployeeRecognition

At Karius, we celebrate the rich legacy, culture, and contributions of Black leaders, innovators, and pioneers throughout history. Black History Month is a time to reflect on the profound impact of Black individuals in shaping our world and to continue advocating for diversity, equity, and inclusion in every aspect of life. Together, let’s celebrate Black excellence, elevate Black voices, and work toward a more equitable future for all.

A new guideline from the American Society of Transplantation and Cellular Therapy (ASTCT) states the Karius Test? can be used to diagnose infections in patients who have undergone Hematopoietic Cell Transplantation (HCT) For patients who have undergone HCT, non-Aspergillus invasive mold infections (NAIMI), represent a rare but potentially lethal risk that can be challenging to diagnose. The ASTCT recently released a guideline that focuses on the management and prevention of NAIMI in HCT Recipients. The ASTCT guideline states, “Plasma mcfDNA (e.g. Karius) can be considered in situations where NAIMI is suspected, and conventional PCR approaches fail to identify a pathogen” and in cases where the diagnosis is particularly challenging. The guideline highlights the potential utility of the Karius Test for early detection and management of pneumonia, including fungal pneumonia, in immunocompromised patients. To discover more about how the Karius Test can help identify the cause of infection, please visit https://hubs.li/Q036Dzpy0.